Pall Inactive 10-Q2005 Q1 Quarterly report

Filed: 10 Dec 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: abnormal, Aeropower, affiliated, affirmative, Agent, agreement, approach, approached, ARB, attain, bear, behalf, biopharmaceutical, BioSepra, borrowed, borrowing, brought, capacity, cent, centered, certification, Chapter, chromatography, Ciphergen, clarify, clearer, complaint, component, conduct, conform, Congressional, consecutive, consideration, contemplate, contemplated, conversion, costly, counsel, coverage, create, creating, Creation, customary, deduction, deemed, Department, dependence, description, diminution, discovered, display, District, division, downturn, Eastern, EBITDA, enable, enrollment, EPA, exceed, exercise, explanatory, extensive, fact, fit, forma, greater, guidance, handling, hope, identification, idle, ii, immune, INACTINE, issuable, IV, law, leaner, LIBOR, loan, macroelectronic, manner, marking, mature, Maximum, merit, minimum, modified, modifying, NASDAQ, nature, notification, overaccrual, past, pathogen, patient, permanently, permission, plaintiff, population, prime, principally, pro, projected, projection, property, proposed, protein, provision, purification, qualify, reclassified, recurring, REO, repatriated, repatriation, repay, restated, revenue, simplify, Simultaneously, structure, substantive, sued, surgical, suspension, syndicate, temporary, thereunder, tighter, titled, uld, ultimately, undistributed, unrepatriated, usage, wo

Removed: adjusted, annualized, April, Backlog, biotechnology, broad, buying, care, clinical, comparison, conflict, consolidate, consolidation, critical, difficult, eliminate, entity, evenly, expiration, expressed, extremely, fastest, favorably, FIN, formulating, FSG, funding, goal, identifying, impacted, intention, Interpretation, Iraqi, January, methodology, occur, offer, original, pharmaceutical, portfolio, realignment, realized, redundant, refinance, research, satisfaction, Specialty, spending, synergistic, typically, unpaid, volatile

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Pall similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Pall Corporation (“the Company”) on Form 10-Q for the quarterly period ending October 31, 2004, as filed with the Securities and Exchange Commission on the date hereof (“the Report”), I, Eric Krasnoff, Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

December 10, 2004

/s/ Eric Krasnoff
Eric Krasnoff
Chief Executive Officer